Seres Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Seres Therapeutics, Inc. (MCRB) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-03-12
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-12-31 was $0.00.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-06-30 was $0.00.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $0.00.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $12.00K, a 75.00% decline from fiscal 2022.
- Seres Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $48.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $1.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $1.00K derived: sum of 3 quarters · filed 2026-03-12 | -$2.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.00K derived: sum of 2 quarters · filed 2026-03-12 | -$2.00K derived: sum of 3 quarters · filed 2026-03-12 | $12.00K 10-K · filed 2026-03-12 |
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-13 | -$2.00K derived: sum of 2 quarters · filed 2024-11-13 | $12.00K 10-Q · filed 2024-11-13 | $118.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -$3.00K 10-Q · filed 2024-08-13 | $11.00K 10-Q · filed 2024-08-13 | $117.00K derived: sum of 3 quarters · filed 2025-03-13 | $255.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-08 | $120.00K derived: sum of 2 quarters · filed 2025-03-13 | $258.00K derived: sum of 3 quarters · filed 2025-03-13 | $217.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $244.00K derived: sum of 2 quarters · filed 2025-03-13 | $203.00K derived: sum of 3 quarters · filed 2025-03-13 | $48.00K 10-K · filed 2025-03-13 |
| 2022-09-30 | $138.00K 10-Q · filed 2023-11-02 | $97.00K derived: sum of 2 quarters · filed 2023-11-02 | -$58.00K 10-Q · filed 2023-11-02 | -$129.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$41.00K 10-Q · filed 2023-08-08 | -$196.00K 10-Q · filed 2023-08-08 | -$267.00K derived: sum of 3 quarters · filed 2024-03-05 | -$268.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$155.00K 10-Q · filed 2023-05-09 | -$226.00K derived: sum of 2 quarters · filed 2024-03-05 | -$227.00K derived: sum of 3 quarters · filed 2024-03-05 | -$200.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$72.00K derived: sum of 2 quarters · filed 2024-03-05 | -$45.00K derived: sum of 3 quarters · filed 2024-03-05 | -$13.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | -$1.00K 10-Q · filed 2022-11-02 | $26.00K derived: sum of 2 quarters · filed 2022-11-02 | $58.00K 10-Q · filed 2022-11-02 | $9.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $27.00K 10-Q · filed 2022-08-03 | $59.00K 10-Q · filed 2022-08-03 | $10.00K derived: sum of 3 quarters · filed 2023-03-07 | $11.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $32.00K 10-Q · filed 2022-05-04 | -$17.00K derived: sum of 2 quarters · filed 2023-03-07 | -$16.00K derived: sum of 3 quarters · filed 2023-03-07 | -$5.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$48.00K derived: sum of 2 quarters · filed 2023-03-07 | -$37.00K derived: sum of 3 quarters · filed 2023-03-07 | -$47.00K 10-K · filed 2023-03-07 |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-10 | $12.00K derived: sum of 2 quarters · filed 2021-11-10 | $2.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $11.00K 10-Q · filed 2021-08-03 | $1.00K 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | -$10.00K 10-Q · filed 2021-05-04 | |||
| 2019-09-30 | $7.00K 10-Q · filed 2020-11-09 | $7.00K 10-Q · filed 2020-11-09 | ||
| 2018-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $29.00K derived: sum of 2 quarters · filed 2021-03-02 | $106.00K derived: sum of 3 quarters · filed 2021-03-02 | $146.00K 10-K · filed 2021-03-02 |
| 2018-09-30 | $20.00K 10-Q · filed 2019-11-05 | $97.00K derived: sum of 2 quarters · filed 2019-11-05 | $137.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $77.00K 10-Q · filed 2019-08-06 | $117.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $40.00K 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $3.00K 10-K · filed 2020-03-02 | |||
| 2016-12-31 | -$179.00K 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |